|
Showing the most relevant articles for your search:NASDAQ:FLKS | Date | Time | Source | Headline | Symbol | Company | | 06/09/2016 | 12:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/09/2016 | 12:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/09/2016 | 12:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/07/2016 | 10:06AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/03/2016 | 8:00AM | Business Wire | Flex Pharma Presenting at Upcoming Investor Conferences in June 2016 | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/02/2016 | 5:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/02/2016 | 8:00AM | PR Newswire (US) | Scientific Breakthrough In Sports Nutrition To Change The Game For Millions Of Endurance Athletes | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/02/2016 | 7:30AM | Business Wire | Flex Pharma Launches First Consumer Product Scientifically Proven to Prevent and Treat Muscle Cramps | NASDAQ:FLKS | Flex Pharma, Inc. |
| 06/01/2016 | 10:21AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/27/2016 | 12:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/25/2016 | 8:00AM | Business Wire | Flex Pharma Initiates Human Efficacy Study with Single Molecule Tablet in Nocturnal Leg Cramps | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/24/2016 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/23/2016 | 11:43AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/19/2016 | 5:06PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/19/2016 | 8:45AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/17/2016 | 10:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/17/2016 | 8:40AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/13/2016 | 4:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/13/2016 | 10:02AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/11/2016 | 10:16AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/04/2016 | 5:36PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/04/2016 | 8:11AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 05/04/2016 | 7:00AM | Business Wire | Flex Pharma Reports First Quarter 2016 Financial Results | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/27/2016 | 8:00AM | Business Wire | Flex Pharma to Report First Quarter 2016 Results on May 4, 2016 | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/27/2016 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/19/2016 | 4:40PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/19/2016 | 4:01PM | Business Wire | Flex Pharma’s Positive Human NLC Study Selected for Presentation at AAN Annual Meeting | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/08/2016 | 5:00PM | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:FLKS | Flex Pharma, Inc. |
| 04/06/2016 | 8:00AM | Business Wire | Flex Pharma Collaborator Penn State Presents Positive Human Muscle Cramp Data | NASDAQ:FLKS | Flex Pharma, Inc. |
| 03/31/2016 | 3:59PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:FLKS | Flex Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:FLKS |
|